Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 3Plasma cell 1Myeloid 1Classical hematology 1CNS 1

Conditions

Myelodysplastic Syndromes 111Leukemia, Myeloid, Acute 106Leukemia 67Leukemia, Myelomonocytic, Chronic 35Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35Myeloproliferative Disorders 30Anemia, Refractory, with Excess of Blasts 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Blast Crisis 24Leukemia, Myeloid, Chronic-Phase 21Congenital Abnormalities 20Myelodysplastic-Myeloproliferative Diseases 15Lymphoma 14Leukemia, Myeloid, Accelerated Phase 14Lymphoma, Non-Hodgkin 13Leukemia, Biphenotypic, Acute 13Leukemia, Monocytic, Acute 12Leukemia, Myelomonocytic, Acute 11Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 11Leukemia, Megakaryoblastic, Acute 11Leukemia, Erythroblastic, Acute 11Hodgkin Disease 11Recurrence 8Primary Myelofibrosis 8Multiple Myeloma 8Leukemia, Lymphocytic, Chronic, B-Cell 8Burkitt Lymphoma 8Lymphoma, Mantle-Cell 7Lymphoma, Large-Cell, Immunoblastic 7Lymphoma, Large B-Cell, Diffuse 7

Interventions

Amifostine 2sargramostim 1Mitoxantrone 1Epoetin Alfa 1Cytarabine 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Cytarabine × Myeloid × Clear all
NCT00003407 2023-02-02

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Rush University Medical Center

Phase 2 Withdrawn
MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡